ALX Oncology Holdings Inc (ALXO)
15.36
-1.26
(-7.58%)
USD |
NASDAQ |
May 03, 16:00
15.36
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings 1 Year Total Returns (Daily): 151.0% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 151.0% |
| May 02, 2024 | 187.3% |
| May 01, 2024 | 161.0% |
| April 30, 2024 | 186.5% |
| April 29, 2024 | 185.0% |
| April 26, 2024 | 197.9% |
| April 25, 2024 | 207.3% |
| April 24, 2024 | 196.5% |
| April 23, 2024 | 158.3% |
| April 22, 2024 | 137.2% |
| April 19, 2024 | 214.5% |
| April 18, 2024 | 237.8% |
| April 17, 2024 | 231.5% |
| April 16, 2024 | 201.9% |
| April 15, 2024 | 168.5% |
| April 12, 2024 | 180.8% |
| April 11, 2024 | 189.0% |
| April 10, 2024 | 171.4% |
| April 09, 2024 | 177.3% |
| April 08, 2024 | 172.8% |
| April 05, 2024 | 179.2% |
| April 04, 2024 | 157.2% |
| April 03, 2024 | 134.3% |
| April 02, 2024 | 137.2% |
| April 01, 2024 | 143.8% |
| Date | Value |
|---|---|
| March 28, 2024 | 129.0% |
| March 27, 2024 | 128.7% |
| March 26, 2024 | 140.1% |
| March 25, 2024 | 151.5% |
| March 22, 2024 | 144.6% |
| March 21, 2024 | 160.1% |
| March 20, 2024 | 160.3% |
| March 19, 2024 | 142.3% |
| March 18, 2024 | 129.6% |
| March 15, 2024 | 117.7% |
| March 14, 2024 | 112.4% |
| March 13, 2024 | 106.0% |
| March 12, 2024 | 129.5% |
| March 11, 2024 | 149.7% |
| March 08, 2024 | 143.8% |
| March 07, 2024 | 154.1% |
| March 06, 2024 | 127.6% |
| March 05, 2024 | 126.5% |
| March 04, 2024 | 125.5% |
| March 01, 2024 | 130.2% |
| February 29, 2024 | 121.6% |
| February 28, 2024 | 119.2% |
| February 27, 2024 | 145.7% |
| February 26, 2024 | 150.8% |
| February 23, 2024 | 127.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.09%
Minimum
Jun 16 2022
237.8%
Maximum
Apr 18 2024
-21.90%
Average
-52.42%
Median
1 Year Total Returns (Daily) Benchmarks
| Bristol-Myers Squibb Co | -31.15% |
| Nurix Therapeutics Inc | 36.54% |
| Exelixis Inc | 14.00% |
| Geron Corp | 47.19% |
| Verastem Inc | 106.4% |